Background Alzheimer's disease is a neurodegenerative disorder. Therapeutically, a
transplantation of bone marrow mesenchymal stem cells (BMMSCs) can play a beneficial …

Mesenchymal stem cells (MSCs) have great potential for cell therapy in regenerative
medicine, including liver disease. Even though ongoing research is dedicated to the goal of …

The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates
neuropathology and improves cognitive deficits in animal models with Alzheimer's disease …

The dynamic relation between stem cells and their niche governs self-renewal and
progenitor cell deployment. The chemokine CXCL12 (CXC motif ligand 12) and its signaling …

Alzheimer's disease (AD) has been called the disease of the century with significant clinical
and socioeconomic impacts. Pharmacological treatment has limited efficacy and only …

Neuroinflammation is regarded as one of the pathogenic factors of Alzheimer disease (AD).
Previously, we showed that mice regularly injected with bacterial lipopolysaccharide (LPS) …

Alzheimer's disease (AD) is a neurodegenerative disease with complex pathologic and
biologic characteristics. Extracellular β-amyloid deposits, such as senile plaques, and …

Neurodegenerative diseases (NDDs), which are chronic and progressive diseases, are a
growing health concern. Among the therapeutic methods, stem-cell-based therapy is an …

It is unknown whether transplantation of bone marrow mesenchymal stem cells (BM-MSCs)
can repair spinal cord ischemia-reperfusion injury (SCII) in a rat model through an anti …

Toll-like receptor 4 (TLR4) is a pattern-recognizing receptor that can bind exogenous and
endogenous ligands. It is expressed by acute myeloid leukemia (AML) cells, several bone …